Did you know that Colorado Eye Consultants has a robust clinical research department? Our research department partners with pharmaceutical companies to test cutting edge therapies for a wide range of ophthalmic disorders and diseases. With the help and participation of our patients, we can submit the needed data to the pharmaceutical companies to advance these therapies for approval for public use.
Our current research studies include:
Intended for patients with thinning corneal conditions such as keratoconus, pellucid marginal degeneration, and LASIK induced corneal ectasia. This treatment is intended to strengthen and stop the thinning of the cornea, thereby helping to keep vision from deteriorating.
Reading glasses in an eye drop! Innovative therapies to eliminate the need for reading glasses.
For our patients with dry eye secondary to Sjogren’s Syndrome.
A study looking at the genetic causes of macular degeneration to advance potential therapies.
Testing a new use for a drug that is already approved by the FDA for other conditions.
Studying long-term therapy in patients who have shingles of the eye. The medication used in this trial has been approved by the FDA for long-term use in other conditions.
Also known as neurotrophic keratopathy, causes decreased corneal sensitivity and poor corneal healing. A regenerative new therapy for those suffering from corneal defects secondary to neurotrophic keratitis.
If you are interested in participating in our studies, please ask our Research Team for more details!
Colorado Eye Consultants is dedicated to the preservation of sight and providing patients with the quality of life they deserve. Our patients receive personalized care by knowledgeable and experienced board certified ophthalmologists to ensure the clarity needed to see the most important things in their world. Your vision is our utmost priority and we offer same day appointments to ensure you get the care you deserve!Request an Appointment